Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapies for treating cancer with niraparib and PD-1 inhibitors

Combination therapies for treating cancer with niraparib and PD-1 inhibitors

US Patent 11661453 · Granted May 30, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Display panel and display apparatus2025
Compounds and methods for the targeted degradation of androgen receptor2025
Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc bindi2025
Modulators of BCL6 proteolysis and associated methods of use2025
Modulators of estrogen receptor proteolysis and associated methods of use2025
Compounds and methods for the enhanced degradation of targeted proteins2025
Cereblon ligands and bifunctional compounds comprising the same2025
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estr2025
SHP2 phosphatase allosteric inhibitor2025
Accelerating fibrosarcoma protein degrading compounds and associated methods of 2024
Compounds and methods for the targeted degradation of bromodomain- containing pr2024
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen recepto2024